分享
首長信箱
分享
2023年期刊論文
引用 (2)
2024/5/3 9:48:24
77
● (SCI IF 17.521)陳正哲、法雨辰、郭彥佑、劉怡均、林芝宇、王馨卉、呂育寰、江雨韓、楊家銘、吳立真 Thiolated Mesoporous Silica Nanoparticles as an Immunoadjuvant to Enhance Efficacy of Intravesical Chemotherapy for Bladder Cancer.硫醇化奈米載體作為免疫佐劑可增強膀胱癌膀胱內化療的療效
期刊: Advanced Science， 先進科學
● (SCI IF 2.435)李建儀、王賢祥、盧嘉文、陳卷書、程千里、洪晟鈞、裘坤元、徐倩儀、楊晨洸 First-line Chemotherapy Response Is Associated With Clinical Outcome During Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma:A Real World Retrospective Study
期刊: ANTICANCER RESEARCH
● (SCI IF 2.435)李建儀、王賢祥、陳卷書、楊晨洸、盧嘉文、程千里、洪晟鈞、陳淑妍、徐倩儀、裘坤元 Efficacy of Novel Hormone Agents in the Treatment of Metastatic Castration-resistant Prostate Cancer: A Real-world Retrospective Study
期刊: ANTICANCER RESEARCH
● (SCI IF 2.435)張瓈文、王賢祥、楊晨洸、盧嘉文、陳卷書、程千里、洪晟鈞、裘坤元、李建儀Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate Hyperplasia.
良性前列腺肥大α還原酶抑製劑變後的攝護腺癌風險.
期刊：ANTICANCER RESEARCH
● (SCI IF 4.614)林嘉彥、王賢祥、謝俊瑜、周英二、簡銘賢、溫玉清、謝明儒Impact of Clinicopathological Characteristics and Tissue Inhibitor of Metalloproteinase-3 Polymorphism Rs9619311 on Biochemical Recurrence in Taiwanese Patients with Prostate Cancer.
期刊：International Journal of Environmental Research and Public Health
● (SCI IF 5.075)胡如娟、許齡內、李偉嘉、莊燿吉 、王弘仁Role of Urological Botulinum Toxin-A Injection for Overactive Bladder and Voiding Dysfunction in Parkinson’s Disease or Post-Stroke Patients.
期刊: Toxins (Basel).
● (SCI IF 4.997)張瓈文、洪晟鈞、陳卷書、李建儀、裘坤元、王賢祥、楊晨洸、盧嘉文、陳正哲、王樹吉、林嘉彥、程千里、歐宴泉Geriatric nutritional risk index as a prognostic marker for patients with upper tract urothelial carcinoma receiving radical nephroureterectomy.
期刊: Scientific Reports
● (SCI IF 2.435)楊涵中、張瓈文、李建儀、王賢祥、楊晨洸、陳卷書、盧嘉文、陳正哲、王樹吉、林嘉彥、程千里、歐宴泉、裘坤元、洪晟鈞Complete Cycles of Radium-223 Improve Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer: A Retrospective Study.
鐳223完整療程對轉移去勢失效攝護腺癌的影響: 回朔性研究
期刊: Anticancer research
● (SCI IF 3.111)楊晨洸、楊啟瑞、歐宴泉、程千里、賀昊中、裘坤元、王賢祥、李建儀、陳卷書、洪啟峰、王樹吉、林嘉彥、洪晟鈞 Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer.
前列腺特異性抗原密度和術前 MRI 結果作為高危和極高危前列腺癌生化復發的預測指標
期刊: ONCOLOGY LETTERS
● (SCI IF 3.871)楊晨洸、查岱龍、張延驊、黃書彬、林仁泰、王賢祥、黃昭淵、馮思中
Darolutamide for non-metastatic castration-resistant prostate cancer:Efficacy, safety, and clinical perspectives of use Darolutamide
治療非轉移性去勢抵抗性前列腺癌：療效、安全性和臨床應用前景
期刊: JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
● (SCI IF 3.456)盧嘉文、裘坤元
Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history :A longitudinal cohort study.
無癌症病史的腎移植受者新發泌尿系統惡性腫瘤的時間趨勢：一項縱向隊列研究
期刊: Clin Transplant
● (SCI IF 3.752)薛承勛、張瓈文、裘坤元、洪晟鈞、陳俊朋、李建儀
Chronic kidney disease, preoperative use of antispasmodics and lower resected prostate volume ratios are risk factors for postoperative use of adrenergic Alpha-blockers and antispasmodics
慢性腎病、術前使用解痙藥和較低的前列腺切除體積比是術後使用腎上腺素能α受體阻滯劑和解痙藥的危險因素
期刊:PLOS ONE
● (SCI IF 2.435)張瓈文、王賢祥、楊晨洸、盧嘉文、陳卷書、程千里、洪晟鈞、裘坤元、徐倩儀、李建儀
Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate Hyperplasia
5甲型還原酶抑制劑對攝護腺疾病治療的影響
期刊:ANTICANCER PEREARCH
● (SCI IF 2.48)李建儀、王賢祥、陳卷書、楊晨洸、盧嘉文、程千里、洪晟鈞、陳淑妍、徐倩儀、裘坤元
Efficacy of Novel Hormone Agents in the Treatment of Metastatic Castration-resistant Prostate Cancer: A Real-world Retrospective Study
期刊: ANTICANCER RESEARCH
● (SCI IF 3.642) 林嘉彥、王淳理、王賢祥、楊晨洸、李建儀、陳卷書、洪晟鈞、裘坤元、程千里、歐宴泉、楊順發 WWOX Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical Prostatectomy
WWOX 多態性作為根治性前列腺切除術後局限性前列腺癌生化復發的預測因子
期刊: Int J Med Sci
● (SCI IF 3.0)顏琮翰、王賢祥、楊晨洸、盧嘉文、陳卷書、程千里、陳俊朋、楊啟瑞、李建儀
Risk analysis of subsequent therapies after first-line chemotherapy in advanced testicular cancer patients
晚期睾丸癌一線化療後後續治療的風險分析
期刊: J Chin Med Assoc .
● (SCI IF 3.5)邱俊凱、張瓈文、李建儀、王賢祥、楊晨洸、陳卷書、盧嘉文、程千里、裘坤元、洪晟鈞
Metastasectomy Improves Overall Survival in Metastatic Renal Cell Carcinoma: A Retrospective Cohort Study
轉移病灶切除改善轉移腎細胞癌的整體存活率:回朔性研究
期刊: Anticancer research
● (SCI IF 1.014)盧嘉文、裘坤元
Lifetime Risk of Hepatorenal Events Assessed in Longitudinal Cohort of Renal Transplant Recipients with HBV Infection.
TRANSPLANTATION PROCEEDINGS
● (SCI IF 2.3)倪雪雰、李建儀、王賢祥、洪晟鈞、楊晨洸、陳卷書 Prognostic factors of Extramammary Paget's Disease: A retrospective study at a medical center in Taiwan.
In Vivo.
● (SCI IF 2.3)賴谷順、李建儀、王賢祥、陳卷書、楊晨洸、林嘉彥、洪晟鈞、賀昊中、歐宴泉、裘坤元、楊順發
Influence of Surgical Complications on Outcomes in Kidney Transplantation Patients
In Vivo.
● (SCI IF 3.9)張瓈文、洪晟鈞、周英二、陳卷書、李建儀、林嘉彥、王賢祥、楊順發
The impacts of MACC1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.
J Cancer.
● (SCI IF 3.752)賴谷順、李建儀、王賢祥、陳卷書、楊晨洸、林嘉彥、洪晟鈞、裘坤元、楊順發 Real world treatment sequences and outcomes for metastatic renal cell carcinoma,
真實世界對於轉移性腎細胞癌的治療順序與結果
期刊:PLoS One
● (SCI IF 1.014)盧嘉文、裘坤元 ComparativeSurvivalAnalysisofDialysisandRenalTransplantationinHBV-InfectedEnd-StageRenalDiseasePatients.
期刊:TRANSPLANTATION PROCEEDINGS
● (SCI IF 1.014)盧嘉文、裘坤元 ComparativeSurvivalAnalysisofDialysisandRenalTransplantationinHBV-InfectedEnd-StageRenalDiseasePatients.
期刊:TRANSPLANTATION PROCEEDINGS